In vitro synergy studies based on tazobactam/piperacillin against clinical isolates of metallo-β-lactamase-producing Pseudomonas aeruginosa

被引：3

作者：

Fujimura, Shigeru ^{[1
]}

Takane, Hidenari ^{[1
]}

Nakano, Yoshihisa ^{[1
]}

Watanabe, Akira ^{[1
]}

机构：

[1] Tohoku Univ, Inst Dev Aging & Canc, Res Div Dev Antiinfect Agents, Sendai, Miyagi 980, Japan

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2009年 / 64卷 / 05期

关键词：

chequerboard; arbekacin; antipseudomonal agents; pulmonary infections;

D O I：

10.1093/jac/dkp333

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：1115 / 1116

页数：2

共 7 条

[1] Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies [J].

Bajaksouzian, S ;

Visalli, MA ;

Jacobs, MR ;

Appelbaum, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1073-1076

[2]

Ciofu O, 2003, APMIS, V111, P4

[3]

Clinical and Laboratory Standards Institute, 2006, M100S16 CLSI

[4] PSEUDOMONAS-AERUGINOSA SEROTYPE O-12 OUTBREAK STUDIED BY ARBITRARY PRIMER PCR [J].

ELAICHOUNI, A ;

VERSCHRAEGEN, G ;

CLAEYS, G ;

DEVLEESCHOUWER, M ;

GODARD, C ;

VANEECHOUTTE, M .

JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (03) :666-671

[5]

FUJIMURA S, 2009, JPN J CHEMOTHER, V57, P91

[6] Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections [J].

Li, Jian ;

Nation, Roger L. ;

Turnidge, John D. ;

Milne, Robert W. ;

Coulthard, Kingsley ;

Rayner, Craig R. ;

Paterson, David L. .

LANCET INFECTIOUS DISEASES, 2006, 6 (09) :589-601

[7] Synergy, antagonism, and what the chequerboard puts between them [J].

Odds, FC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) :1-1

← 1 →